Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.91%74.430.0%$2402.36m
NVAXNovavax, Inc. 1.57%170.1399.2%$1227.79m
SRNESorrento Therapeutics, Inc. 4.63%14.241.8%$561.81m
GILDGilead Sciences, Inc. 0.19%68.941.0%$550.36m
AMGNAmgen, Inc. -0.38%240.641.3%$483.55m
REGNRegeneron Pharmaceuticals, Inc. 0.48%624.192.5%$438.75m
BNTXBioNTech SE 0.60%77.540.0%$396.78m
VRTXVertex Pharmaceuticals, Inc. 0.71%275.271.9%$377.82m
BIIBBiogen, Inc. 8.78%302.051.6%$340.47m
VXRTVaxart, Inc. 2.58%9.330.0%$292.69m
ILMNIllumina, Inc. -13.52%345.343.5%$277.47m
EBSEmergent BioSolutions, Inc. 2.35%129.946.4%$180.09m
ALXNAlexion Pharmaceuticals, Inc. -0.69%103.181.9%$168.98m
SGENSeattle Genetics, Inc. -0.26%161.386.0%$165.38m
IBIOiBio, Inc. -3.45%3.920.2%$163.75m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.